When examining Bortezomib’s antitumour effects in MM, researchers observed an indirect suppression of angiogenesis through decreased VEGF levels and a reduction in hypoxia adaptation, indicated by diminished CAIX expression [205,206,208]. Here, VEGFA is linked to Miyoshi myopathy.